Watch our short explainer video to learn what problem we’re solving for clinicians and how our technology works.
Echocardiography uses sound waves to image the heart. Because of its unparalleled safety profile, low cost and ease of deployment echo is the most widely used cardiac imaging test. Heart disease affects almost 50% of people over the age of 40 — making it the biggest killer globally. However, making a diagnosis from echo relies on experienced clinicians having to make qualitative judgements based on only a fraction of the data that is potentially available to them from a typical scan.
Our technology extracts more than 80,000 data points from a single echocardiogram image to overcome subjectivity and increase diagnostic accuracy of coronary heart disease from 80% to >90%.
Our applications analyse all these data points using machine-learning techniques and have the potential to yield new, objective and highly diagnostic metrics about cardiac function and disease.
Anticipating the launch of our first stand-alone stress echocardiography product for cardiologists in 2019, underpinned by clinically-validated and exclusively-licensed intellectual property, we also have a future product pipeline growing out of one of the world’s largest research databases of echo images.
Stay updated with our product launch newsletter
Ultromics is partnered with Oxford Sciences Innovation (OSI)
Ultromics Limited. Registered Office: King Charles House, Park End Street, Oxford, Oxfordshire, United Kingdom, OX1 1JD. Registered No. 10684811.
Copyright © 2017 Ultromics Limited. All rights reserved.